Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
This study is ongoing, but not recruiting participants.
Association Française contre les Myopathies (AFM), Paris
Information provided by (Responsible Party):
First received: February 18, 2011
Last updated: December 27, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 2013|
|Estimated Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|